Business / Finance

RSS
MJFF awards $1.35M to Rhythm for Phase 2 clinical trial of RM-131 for Parkinson's disease

MJFF awards $1.35M to Rhythm for Phase 2 clinical trial of RM-131 for Parkinson's disease

10 Sep 2013
Power Balance Technologies joins NBCF with the new 'Breast Cancer Awareness' Wristband

Power Balance Technologies joins NBCF with the new 'Breast Cancer Awareness' Wristband

10 Sep 2013
Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

Hospira announces EC approval of Inflectra, Europe's first biosimilar mAb therapy

10 Sep 2013
Biogen Idec And Isis Ink Fourth Deal In Two Years

Biogen Idec And Isis Ink Fourth Deal In Two Years

9 Sep 2013
Oncodesign, Banook Central Imaging To Develop Cancer Biomarkers

Oncodesign, Banook Central Imaging To Develop Cancer Biomarkers

9 Sep 2013
Novation and Surgicount Medical sign Innovative Technology agreement

Novation and Surgicount Medical sign Innovative Technology agreement

7 Sep 2013
Regado Biosciences employs over-allotment option to purchase additional shares of common stock

Regado Biosciences employs over-allotment option to purchase additional shares of common stock

7 Sep 2013
PMSI, Progressive Medical collaborate to deliver comprehensive workers' compensation pharmacy benefit management services

PMSI, Progressive Medical collaborate to deliver comprehensive workers' compensation pharmacy benefit management services

7 Sep 2013
Health Care REIT participates in the Bank of America Merrill Lynch 2013 Global Real Estate Conference

Health Care REIT participates in the Bank of America Merrill Lynch 2013 Global Real Estate Conference

7 Sep 2013
Enzymatics buys Boulder-based ArcherDx

Enzymatics buys Boulder-based ArcherDx

7 Sep 2013
UW researchers receive $390,000 from 5 organizations dedicated to fostering technology

UW researchers receive $390,000 from 5 organizations dedicated to fostering technology

7 Sep 2013
Medivir discontinues development of hepatitis B compound MIV-210 on collaboration with Daewoong

Medivir discontinues development of hepatitis B compound MIV-210 on collaboration with Daewoong

7 Sep 2013
Enzymatics Acquires Archerdx For Up To $50M

Enzymatics Acquires Archerdx For Up To $50M

6 Sep 2013
NIH Funds Minority Disease Susceptibility Studies

NIH Funds Minority Disease Susceptibility Studies

6 Sep 2013
Rigel Cuts 30 Jobs, Refocuses On Three Clinical Programs

Rigel Cuts 30 Jobs, Refocuses On Three Clinical Programs

5 Sep 2013
Capsugel Nabs Bend Research

Capsugel Nabs Bend Research

5 Sep 2013
Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

5 Sep 2013
Walgreens’ August sales increased by 5.6% to $6.17 billion

Walgreens’ August sales increased by 5.6% to $6.17 billion

5 Sep 2013
Patheon's Q3 2013 revenues increase 30.4% to $265.7 million

Patheon's Q3 2013 revenues increase 30.4% to $265.7 million

5 Sep 2013
ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

5 Sep 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback